Mechanisms-based therapeutic strategies in type 2 diabetes.
作者信息
Paneni Francesco, Costantino Sarah
出版信息
Cardiovasc Diagn Ther. 2015 Oct;5(5):340-2. doi: 10.3978/j.issn.2223-3652.2015.09.05.
Abstract
摘要
相似文献
1
Mechanisms-based therapeutic strategies in type 2 diabetes.
Cardiovasc Diagn Ther. 2015 Oct;5(5):340-2. doi: 10.3978/j.issn.2223-3652.2015.09.05.
2
Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Vitam Horm. 2014;95:195-222. doi: 10.1016/B978-0-12-800174-5.00008-9.
3
Mitochondrial biogenesis: pharmacological approaches.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
4
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms.
Endocr Rev. 2018 Oct 1;39(5):629-663. doi: 10.1210/er.2017-00191.
5
Can Diabetes Heal?- From Observations to Perspectives.
Curr Diabetes Rev. 2016;12(3):184-98. doi: 10.2174/1573399811666150702125702.
6
Natural cures for type 1 diabetes: a review of phytochemicals, biological actions, and clinical potential.
Curr Med Chem. 2013;20(7):899-907.
7
Type 2 diabetes mellitus: an evolving therapeutic approach.
P N G Med J. 2001 Sep-Dec;44(3-4):124-30.
8
Phytopharmacological Strategies in the Management of Type 2 Diabetes .
Foods. 2020 Mar 2;9(3):271. doi: 10.3390/foods9030271.
9
[Will the theory of metabolic memory change our therapeutic strategies in the face of type 2 diabetes?].
Rev Med Suisse. 2005 Jun 1;1(22):1485-6, 1488-90.
10
Current and future treatment strategies for type 2 diabetes: the beta-cell as a therapeutic target.
Curr Opin Investig Drugs. 2001 Nov;2(11):1568-74.
引用本文的文献
1
5'-AMP-activated protein kinase plays an essential role in geniposide-regulated glucose-stimulated insulin secretion in rat pancreatic INS-1 β cells.
J Nat Med. 2017 Jan;71(1):123-130. doi: 10.1007/s11418-016-1038-5. Epub 2016 Sep 7.
本文引用的文献
1
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.
JACC Heart Fail. 2015 Feb;3(2):136-45. doi: 10.1016/j.jchf.2014.08.004.
2
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
Eur Heart J. 2013 Aug;34(31):2444-52. doi: 10.1093/eurheartj/eht142. Epub 2013 Apr 26.
3
Diabetic cardiomyopathy revisited.
Circulation. 2007 Jun 26;115(25):3213-23. doi: 10.1161/CIRCULATIONAHA.106.679597.
4
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
N Engl J Med. 1998 Jul 23;339(4):229-34. doi: 10.1056/NEJM199807233390404.
5
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
JAMA. 1994 Mar 16;271(11):840-4.
Zotero 插件